2009年罗马基金会终点与结果会议：优化功能性胃肠病的临床试验 - Suppr

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

作者信息

Chang Lin, Drossman Douglas A

机构信息

Center for Neurobiology of Stress, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

出版信息

Am J Gastroenterol. 2010 Apr;105(4):722-30. doi: 10.1038/ajg.2010.49.

DOI:10.1038/ajg.2010.49

PMID:20372120

Abstract

摘要

相似文献

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

Am J Gastroenterol. 2010 Apr;105(4):722-30. doi: 10.1038/ajg.2010.49.

International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.

Fed Regist. 2001 May 14;66(93):24390-1.

International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.

Fed Regist. 2010 Jan 21;75(13):3471-2.

International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.

Fed Regist. 2001 Jul 13;66(135):36791-2.

International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.

Fed Regist. 1998 Sep 16;63(179):49583-98.

International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

Fed Regist. 2005 Oct 20;70(202):61134-5.

New clinical trials policy at FDA.

Nat Biotechnol. 2006 Sep;24(9):1043. doi: 10.1038/nbt0906-1043. Epub 2006 Sep 1.

Good clinical practices.

Qual Assur. 1994 Jun;3(2):126-30.

Researchers left to guess at outcomes of most cancer clinical trials.

J Natl Cancer Inst. 2009 Jan 21;101(2):72-4. doi: 10.1093/jnci/djn495. Epub 2009 Jan 13.

The placebo: promise and compromise.

Tenn Med. 2005 Mar;98(3):138-9.

引用本文的文献

Pharmacological treatments for patients with irritable bowel syndrome: An umbrella review of systematic reviews and meta-analyses.

Medicine (Baltimore). 2019 Aug;98(32):e15920. doi: 10.1097/MD.0000000000015920.

Activation of Peripheral Blood CD4+ T-Cells in IBS is not Associated with Gastrointestinal or Psychological Symptoms.

Sci Rep. 2019 Mar 6;9(1):3710. doi: 10.1038/s41598-019-40124-5.

A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.

Qual Life Res. 2016 Dec;25(12):2985-2995. doi: 10.1007/s11136-016-1421-4. Epub 2016 Sep 29.

Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.

Br J Nutr. 2015 Nov 28;114(10):1638-46. doi: 10.1017/S0007114515003347. Epub 2015 Sep 18.

Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects.

Neurogastroenterol Motil. 2014 Feb;26(2):205-14. doi: 10.1111/nmo.12249. Epub 2013 Oct 25.

Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome.

PLoS One. 2012;7(10):e48135. doi: 10.1371/journal.pone.0048135. Epub 2012 Oct 23.

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.

Aliment Pharmacol Ther. 2010 Nov;32(9):1192-202. doi: 10.1111/j.1365-2036.2010.04443.x. Epub 2010 Aug 30.

Constipation: Linaclotide--a stimulating new drug for chronic constipation.

Nat Rev Gastroenterol Hepatol. 2010 Jul;7(7):365-6. doi: 10.1038/nrgastro.2010.84.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

作者信息

Chang Lin, Drossman Douglas A

机构信息

Center for Neurobiology of Stress, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

出版信息

Am J Gastroenterol. 2010 Apr;105(4):722-30. doi: 10.1038/ajg.2010.49.

DOI:10.1038/ajg.2010.49

PMID:20372120

Abstract

摘要

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

作者信息

机构信息

出版信息

相似文献

引用本文的文献